JP2020100570A - Skin external preparation - Google Patents

Skin external preparation Download PDF

Info

Publication number
JP2020100570A
JP2020100570A JP2018237880A JP2018237880A JP2020100570A JP 2020100570 A JP2020100570 A JP 2020100570A JP 2018237880 A JP2018237880 A JP 2018237880A JP 2018237880 A JP2018237880 A JP 2018237880A JP 2020100570 A JP2020100570 A JP 2020100570A
Authority
JP
Japan
Prior art keywords
oil
squalane
external preparation
skin
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018237880A
Other languages
Japanese (ja)
Other versions
JP6586506B1 (en
Inventor
美和 笹岡
Miwa Sasaoka
美和 笹岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2018237880A priority Critical patent/JP6586506B1/en
Application granted granted Critical
Publication of JP6586506B1 publication Critical patent/JP6586506B1/en
Publication of JP2020100570A publication Critical patent/JP2020100570A/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Cosmetics (AREA)

Abstract

To provide skin external preparations in which moisturizing effect is synergistically improved by using particular ingredients together.SOLUTION: The present invention provides a skin external preparation containing the following components (A) to (D): (A) oil-soluble extract of Anthemis nobile plants; (B) meadow foam oil; (C) squalane; and (D) argan oil.SELECTED DRAWING: Figure 1

Description

本発明は、特定の成分を併用することにより高い保湿効果を有する皮膚外用剤に関する。 The present invention relates to a skin external preparation having a high moisturizing effect by using a combination of specific components.

ローマカミツレ(Anthemis nobilis)抽出物を含有する皮膚外用剤は、高い皮膚保湿効果,美肌効果及び肌荒れ改善効果を有し、さらに皮膚とのなじみが良く、安定性及び安全性に優れることが知られている(特許文献1)。メドウフォーム油を含有する皮膚外用剤は、皮膚を柔らかくする効果を有することが知られている(特許文献2)。スクワランは、肌理改善効果,表皮のターンオーバー改善効果及び表皮バリア機能の改善効果を有する皮膚外用剤に含有されることが知られている(特許文献3)。アルガンバターが化粧料に配合されることが知られている(特許文献4)。 It is known that the external preparation for the skin containing the extract of Anthemis nobilis has a high skin moisturizing effect, a beautiful skin effect and a rough skin improving effect, and is well compatible with the skin and excellent in stability and safety. (Patent Document 1). It is known that an external preparation for skin containing meadow foam oil has an effect of softening the skin (Patent Document 2). Squalane is known to be contained in a skin external preparation having a texture improving effect, an epidermal turnover improving effect, and an epidermal barrier function improving effect (Patent Document 3). It is known that argan butter is added to cosmetics (Patent Document 4).

特開2001−354537号公報JP, 2001-354537, A 特開2009−286770号公報JP, 2009-286770, A 特開2016−008188号公報JP, 2016-008188, A 特開2016−138238号公報JP, 2016-138238, A

本発明は、特定の成分を併用することにより、保湿効果が相乗的に向上する皮膚外用剤を提供することを課題とする。 An object of the present invention is to provide an external preparation for skin in which the moisturizing effect is synergistically improved by using a specific component in combination.

本発明は、
下記(A)〜(D)の成分を含有する皮膚外用剤
(A)キク科ローマカミツレ属(Anthemis)植物の油溶性抽出物
(B)メドウフォーム油
(C)スクワラン
(D)アルガン油
を提供する。
The present invention is
An external preparation for skin containing the following components (A) to (D) (A) Oil-soluble extract of a plant belonging to the family Asteraceae (Anthemis) (B) Meadow foam oil (C) Squalane (D) Argan oil is provided. To do.

本発明の皮膚外用剤は、特定の植物の抽出物を併用して用いることにより、保湿効果が相乗的に向上する。 The skin external preparation of the present invention synergistically improves the moisturizing effect when used in combination with an extract of a specific plant.

図1は、成分(A)〜(D)を併用することにより、経表皮水分蒸散量が相乗的に減少することを示す図である。FIG. 1 is a diagram showing that the transepidermal water loss is synergistically reduced by using the components (A) to (D) together.

以下本発明を実施するための形態を説明する。 Hereinafter, modes for carrying out the present invention will be described.

本発明の皮膚外用剤は、化粧品、医薬部外品、医薬品等のいずれの用途にも用いられ得る。 The external preparation for skin of the present invention can be used for any application such as cosmetics, quasi drugs, and pharmaceuticals.

本発明の皮膚外用剤に配合するキク科ローマカミツレ属(Anthemis)の植物の抽出物は、ローマカミツレ(Anthemis nobilis),キゾメカミツレ(A. arvensis),コウヤカミツレ(A. tinctoria)等から得られる抽出物であれば特に限定されないが、本発明の効果の点からローマカミツレを用いることが好ましい。抽出にはすべての部位を用いることができるが、好ましくは花を用いる。 The extract of a plant of the genus Roman chamomile (Anthemis) to be added to the external preparation for skin of the present invention is an extract obtained from Roman chamomile (Anthemis nobilis), Kisomeka mochi (A. arvensis), Koya chamomile (A. tinctoria) and the like. Although it is not particularly limited as long as it is a product, it is preferable to use Roman chamomile from the viewpoint of the effect of the present invention. All sites can be used for extraction, but flowers are preferably used.

抽出方法としては、乾燥させた上述の植物を粉砕し、95容量%エタノールを溶媒として抽出したものを用いる。 As an extraction method, the above-mentioned dried plant is crushed and extracted with 95% by volume of ethanol as a solvent.

本発明における上述の植物抽出物の組成物への配合量としては、好ましくは0.00001〜10質量%、特に0.0001〜8質量%の範囲である。この範囲であれば、製剤及び製剤中の植物の経時安定性に影響を及ぼすことが無く、より高い効果を発揮させることができる。 The amount of the above-mentioned plant extract to be added to the composition of the present invention is preferably in the range of 0.00001 to 10% by mass, particularly 0.0001 to 8% by mass. Within this range, higher effects can be exhibited without affecting the stability of the preparation or the plants in the preparation over time.

本発明の皮膚外用剤に配合するメドウフォーム油はメドウフォーム(L. douglasii)の種子から得られる脂肪油であり、吸着精製処理を行ったものを用いることが、臭い及び酸化安定性の点から好ましい。市販のクロピュア メドフォーム-LQ-(JP)(クローダジャパン株式会社),NIKKOL メドウホーム油(日光ケミカルズ株式会社)等を用いることもできる。 Meadowfoam oil to be added to the external preparation for skin of the present invention is a fatty oil obtained from seeds of Meadowfoam (L. douglasii), and it is possible to use an adsorbent-purified product from the viewpoint of odor and oxidative stability. preferable. It is also possible to use commercially available Kuropure Medfoam-LQ- (JP) (Croda Japan Co., Ltd.), NIKKOL Meadow Home Oil (Nikko Chemicals Co., Ltd.) and the like.

本発明の皮膚外用剤に配合するスクワランは、2,6,10,15,19,23−ヘキサメチルテトラコサンで、深海鮫の肝臓から抽出される動物由来のものとオリーブの果実又は米糠等から抽出される植物由来のものがある。いずれも抽出されたスクワレンに水素添加されたスクワランを用いることが好ましく、特に本発明においては植物由来のスクワランを用いることが好ましい。市販のNIKKOL シュガースクワラン(登録商標)(日本サーファクタント工業株式会社),オリーブスクワラン(高級アルコール工業株式会社),オリザスクワラン(オリザ油化株式会社),植物性スクワラン(株式会社岸本特殊肝油工業所),スーパースクワラン(マルハニチロ株式会社),スクワラン(株式会社岸本特殊肝油工業所),スクワラン(日光ケミカルズ株式会社),スクワラン(マルハニチロ株式会社),精製オリーブスクワラン(日光ケミカルズ株式会社),フィトスクワラン(ソフィーム社),プリピュア 3759-LQ(ユニケマ社)等を用いることもできる。 Squalane to be added to the skin external preparation of the present invention is 2,6,10,15,19,23-hexamethyltetracosane, which is derived from an animal extracted from the liver of a deep-sea shark and olive fruit or rice bran. Some are of plant origin. In both cases, it is preferable to use hydrogenated squalane in the extracted squalane, and it is particularly preferable to use plant-derived squalane in the present invention. Commercially available NIKKOL Sugar Squalane (registered trademark) (Japan Surfactant Industry Co., Ltd.), Olive Squalane (Higher Alcohol Industry Co., Ltd.), Oriza Squalane (Oriza Yuka Co., Ltd.), Plant Squalane (Kishimoto Special Liver Oil Co., Ltd.), Super Squalane (Maruha Nichiro Co., Ltd.), Squalane (Kishimoto Special Liver Oil Co., Ltd.), Squalane (Nikko Chemicals Co., Ltd.), Squalane (Maruha Nichiro Co., Ltd.), Purified Olive Squalane (Nikko Chemicals Co., Ltd.), Phyto Squalane (Sophiem Co.) , Pure Pure 3759-LQ (Unichema) and the like can also be used.

本発明の皮膚外用剤に配合するアルガン油は、アルガン(Sideroxylon spinosum)の種子から得られる脂肪油である。市販のD-EXTRA アルガンオイル(株式会社ガッスールジャパン・ジャミーラ),アルガンオイル(株式会社ニュートリション・アクト),Lipovol ARGAN(Vantage Specialty Ingredients, Inc.),LIPOFRUCTYL ARGAN LS 9779(BASF Group),Argan Oil Deodorised, Organic (脱臭精製/COSMOSオーガニック対応)(All Organic Treasures GmbH),Argan Oil Cold Pressed, Organic (COSMOSオーガニック対応)(All Organic Treasures GmbH)等を用いることもできる。 The argan oil blended in the external preparation for skin of the present invention is a fatty oil obtained from the seeds of argan (Sideroxylon spinosum). Commercially available D-EXTRA Argan oil (Gassur Japan Jamira Co., Ltd.), Argan oil (Nutrition Act Co., Ltd.), Lipovol ARGAN (Vantage Specialty Ingredients, Inc.), LIPOFRUCTYL ARGAN LS 9779 (BASF Group), Argan Oil Deodorised, Organic (deodorizing/refining/COSMOS organic) (All Organic Treasures GmbH), Argan Oil Cold Pressed, Organic (COSMOS organic) (All Organic Treasures GmbH), etc. can also be used.

本発明における上述の植物の組成物への配合量としては、好ましくは0.01〜99.9質量%の範囲である。この範囲であれば、製剤及び製剤中の植物の経時安定性に影響を及ぼすことが無く、より高い効果を発揮させることができる。 The amount of the above-described plant compounded in the composition of the present invention is preferably in the range of 0.01 to 99.9% by mass. Within this range, higher effects can be exhibited without affecting the stability of the preparation or the plants in the preparation over time.

本発明の皮膚外用剤には上述の必須成分の他に、必要に応じて通常皮膚外用剤に配合される、水性成分、メドウフォーム油,スクワラン及びアルガン油の3種の油以外の油性成分、保湿剤、色素、界面活性剤、紫外線吸収剤、増粘剤、美容成分、香料、高分子物質、防菌防黴剤、アルコール類、粉体、スクラブ剤、生体由来成分等を適宜配合することができる。 In addition to the above-mentioned essential components, the external preparation for skin of the present invention is usually blended in an external preparation for skin as necessary, and is an aqueous component, an oil component other than the three oils of meadow foam oil, squalane and argan oil, Appropriately blend moisturizers, pigments, surfactants, UV absorbers, thickeners, cosmetic ingredients, fragrances, polymeric substances, antibacterial and antifungal agents, alcohols, powders, scrubs, biogenic ingredients, etc. You can

本発明の皮膚外用剤は、例えば、ローション剤、乳剤、軟膏の剤型で用いることができる。また、本発明の皮膚外用剤は、製造方法を問わない。 The external preparation for skin of the present invention can be used, for example, in the form of lotions, emulsions and ointments. The external preparation for skin of the present invention may be produced by any method.

以下、実施例により本発明を具体的に説明するが、これにより本発明の範囲が限定されるものではない。なお、配合量は特に断りのない限り質量%である。 Hereinafter, the present invention will be specifically described with reference to examples, but the scope of the present invention is not limited thereby. The compounding amount is mass% unless otherwise specified.

まず、使用した各成分の調製例を示す。 First, a preparation example of each component used is shown.

[ローマカミツレ抽出物]
ローマカミツレを乾燥後粉砕したものを95容量%エタノールに浸漬し、ろ過後ろ液を採取したものを用いた。
[Roma chamomile extract]
The Roman chamomile was dried and then pulverized, immersed in 95% by volume of ethanol, and the liquid obtained after filtration was used.

[メドウフォーム油]
市販のクローダジャパン株式会社製のクロピュア メドフォーム-LQ-(JP)を用いた。
[Meadow foam oil]
Cropure Medfoam-LQ-(JP) manufactured by Croda Japan Co., Ltd. was used.

[スクワラン]
植物由来のスクワランを用いた。
[Squalane]
Squalane of plant origin was used.

[アルガン油]
市販の株式会社ガッスールジャパン・ジャミーラ製のD-EXTRA アルガンオイルを用いた。
[Argan oil]
The commercially available D-EXTRA argan oil manufactured by Gassur Japan Jamira Co., Ltd. was used.

[保湿効果試験方法]
表1に示した試料を調製し、経表皮水分蒸散量の測定を行った。
[Moisturizing effect test method]
The samples shown in Table 1 were prepared and the transepidermal water loss was measured.

[測定方法]
(1)馴化
被験者は左右前腕内側部を洗浄後、水分をふき取り、温度20±0.5℃、湿度50±5%に調整された室内で15分間安静にし、馴化を行った。
(2)塗布
左右前腕内側部に3cm×3cmの領域を記し、ピペットを用いて9μLを滴下し、指サックをした指で均一に塗布した。
(3)測定
塗布前及び塗布後60分後の経表皮水分蒸散量をVapometerを用いて測定した。経表皮水分蒸散量は塗布前の経表皮水分蒸散量を100とした場合の相対値を算出し、表1に示した。経表皮水分蒸散量は、測定当日の気温、湿度等の影響を受けやすいため、一群の試料は同日に評価し、塗布前の測定も試料を塗布した部位での測定値を相対値の基準とした。
[Measuring method]
(1) Acclimation After rinsing the insides of the left and right forearms, the test subject acclimated by resting for 15 minutes in a room adjusted to a temperature of 20 ± 0.5°C and a humidity of 50 ± 5%.
(2) Application An area of 3 cm×3 cm was marked on the inner parts of the left and right forearms, 9 μL was dropped using a pipette, and applied evenly with a finger sack.
(3) Measurement The transepidermal water loss before and 60 minutes after application was measured using a Vapometer. The transepidermal water loss was calculated as a relative value when the transepidermal water loss before application was 100, and is shown in Table 1. The transepidermal water loss is easily affected by the temperature, humidity, etc. on the day of measurement, so a group of samples was evaluated on the same day, and the measurement before application was also based on the relative value as the measurement value at the site where the sample was applied. did.

Figure 2020100570
Figure 2020100570

表1に示した通り、試料5を塗布することにより、それぞれ単独で塗布した場合と比較して、経表皮水分蒸散量が相乗的に減少していた。 As shown in Table 1, by applying Sample 5, the transepidermal water loss was synergistically reduced as compared with the case where each was applied alone.

[実施例1]クリーム
(1)スクワラン 4.7(質量%)
(2)ステアリン酸 2.0
(3)ローマカミツレ抽出物 0.5
(4)メドウフォーム油 2.6
(5)セタノール 3.6
(6)親油型モノステアリン酸グリセリン 2.0
(7)グリセリン 10.0
(8)アルガン油 2.6
(9)アルギニン(20質量%水溶液) 15.0
(10)精製水 全量を100とする量
(11)カルボキシビニルポリマー(1質量%水溶液) 15.0
(12)水素添加大豆リン脂質 0.1
(13)パラオキシ安息香酸メチル 0.1
[Example 1] Cream (1) Squalane 4.7 (mass%)
(2) Stearic acid 2.0
(3) Roman chamomile extract 0.5
(4) Meadow foam oil 2.6
(5) Cetanol 3.6
(6) Lipophilic type glyceryl monostearate 2.0
(7) Glycerin 10.0
(8) Argan oil 2.6
(9) Arginine (20 mass% aqueous solution) 15.0
(10) Purified water Total amount 100 (11) Carboxyvinyl polymer (1% by mass aqueous solution) 15.0
(12) Hydrogenated soybean phospholipid 0.1
(13) Methyl paraoxybenzoate 0.1

[実施例2]乳液
(1)スクワラン 2.8(質量%)
(2)ローマカミツレ抽出物 0.2
(3)メドウフォーム油 1.5
(4)水素添加大豆リン脂質 0.1
(5)モノステアリン酸ポリオキシエチレン
ソルビタン(20E.O.) 1.3
(6)モノステアリン酸ソルビタン 1.0
(7)グリセリン 4.0
(8)アルガン油 1.5
(9)カルボキシビニルポリマー 0.15
(10)精製水 全量を100とする量
(11)アルギニン(1質量%水溶液) 20.0
(12)パラオキシ安息香酸メチル 0.1
[Example 2] Emulsion (1) Squalane 2.8 (mass%)
(2) Roman chamomile extract 0.2
(3) Meadow foam oil 1.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Polyoxyethylene monostearate
Sorbitan (20 E.O.) 1.3
(6) Sorbitan monostearate 1.0
(7) Glycerin 4.0
(8) Argan oil 1.5
(9) Carboxyvinyl polymer 0.15
(10) Purified water Amount based on total amount of 100 (11) Arginine (1% by mass aqueous solution) 20.0
(12) Methyl paraoxybenzoate 0.1

[実施例3]化粧水
(1)エタノール 15.0(質量%)
(2)ポリオキシエチレン(40E.O.)硬化ヒマシ油 2.0
(3)香料 0.1
(4)精製水 全量を100とする量
(5)クエン酸 0.02
(6)クエン酸ナトリウム 0.1
(7)グリセリン 1.0
(8)ヒドロキシエチルセルロース 0.1
(9)スクワラン 0.25
(10)ローマカミツレ抽出物 0.25
(11)メドウフォーム油 0.25
(12)アルガン油 0.25
[Example 3] Lotion (1) Ethanol 15.0 (mass%)
(2) Polyoxyethylene (40 E.O.) hydrogenated castor oil 2.0
(3) Perfume 0.1
(4) Purified water Amount based on total amount of 100 (5) Citric acid 0.02
(6) Sodium citrate 0.1
(7) Glycerin 1.0
(8) Hydroxyethyl cellulose 0.1
(9) Squalane 0.25
(10) Roman chamomile extract 0.25
(11) Meadow foam oil 0.25
(12) Argan oil 0.25

[実施例4]水性ジェル
(1)(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマー
1.0(質量%)
(2)精製水 全量を100とする量
(3)水酸化ナトリウム(10質量%水溶液) 0.5
(4)パラオキシ安息香酸メチル 0.1
(5)ローマカミツレ抽出物 0.3
(6)メドウフォーム油 0.3
(7)スクワラン 0.3
(8)アルガン油 0.3
(9)香料 0.1
(10)ポリオキシエチレン(60E.O.)硬化ヒマシ油 0.1
Example 4 Aqueous Gel (1) (Acrylate/Alkyl Acrylate (C10-30)) Crosspolymer
1.0 (mass%)
(2) Purified water Amount based on 100 (3) Sodium hydroxide (10% by mass aqueous solution) 0.5
(4) Methyl paraoxybenzoate 0.1
(5) Roman chamomile extract 0.3
(6) Meadow foam oil 0.3
(7) Squalane 0.3
(8) Argan oil 0.3
(9) Perfume 0.1
(10) Polyoxyethylene (60 E.O.) hydrogenated castor oil 0.1

[実施例5]クレンジング料
(1)スクワラン 66.5(質量%)
(2)イソステアリン酸ポリオキシエチレングリセリル 15.0
(3)精製水 全量を100とする量
(4)ローマカミツレ抽出物 0.5
(5)メドウフォーム油 7.0
(6)アルガン油 7.0
[Example 5] Cleansing agent (1) Squalane 66.5 (mass%)
(2) Polyoxyethylene glyceryl isostearate 15.0
(3) Purified water with the total amount being 100 (4) Roman chamomile extract 0.5
(5) Meadow foam oil 7.0
(6) Argan oil 7.0

Claims (1)

下記(A)〜(D)の成分を含有する皮膚外用剤。
(A)キク科ローマカミツレ属(Anthemis)植物の油溶性抽出物
(B)メドウフォーム油
(C)スクワラン
(D)アルガン油
A skin external preparation containing the following components (A) to (D).
(A) Oil-soluble extract of the genus Anthemis (Asteraceae) (B) Meadow foam oil (C) Squalane (D) Argan oil
JP2018237880A 2018-12-20 2018-12-20 Topical skin preparation Active JP6586506B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018237880A JP6586506B1 (en) 2018-12-20 2018-12-20 Topical skin preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018237880A JP6586506B1 (en) 2018-12-20 2018-12-20 Topical skin preparation

Publications (2)

Publication Number Publication Date
JP6586506B1 JP6586506B1 (en) 2019-10-02
JP2020100570A true JP2020100570A (en) 2020-07-02

Family

ID=68095445

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018237880A Active JP6586506B1 (en) 2018-12-20 2018-12-20 Topical skin preparation

Country Status (1)

Country Link
JP (1) JP6586506B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023128963A1 (en) * 2021-12-28 2023-07-06 Eczacibasi Tuketim Urunleri Sanayi Ve Ticaret Anonim Sirketi Skin product comprising anthemis rosea subsp. carnea (boiss.) grierson extract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023128963A1 (en) * 2021-12-28 2023-07-06 Eczacibasi Tuketim Urunleri Sanayi Ve Ticaret Anonim Sirketi Skin product comprising anthemis rosea subsp. carnea (boiss.) grierson extract

Also Published As

Publication number Publication date
JP6586506B1 (en) 2019-10-02

Similar Documents

Publication Publication Date Title
KR101189344B1 (en) Self-preserving skin care formulation
KR101964809B1 (en) Inhibitor for NO activator, Anit-inflammation agent containing of the same, Revitalizing cosmetics containing the same and Manufacturing method thereof
US8741271B2 (en) Antimicrobial compositions containing essential oils
JP2008297291A (en) Cosmetic
KR101599254B1 (en) Cosmetic composition for skin moisturizer
JP6404667B2 (en) Transparent cosmetic and method for producing the transparent cosmetic
JP5695678B2 (en) Deodorant containing polyhydric alcohol
KR20170019830A (en) Composition for the natural surfactant and cosmetic composition containing Saponaria officinalis, Yucca Schidigera and Quillaia saponaria MOLINA
JP5765744B2 (en) Preventive or therapeutic agent for atopic dermatitis, and external preparation
JP2023153398A (en) Skin external preparation
JP2020100570A (en) Skin external preparation
WO2015064681A1 (en) Composition for external use
JP4212220B2 (en) Body odor deodorant
JP2009007307A (en) Cosmetic or skin preparation for external use
KR20170019305A (en) Cosmetic composition for skin moisturizer
JP2007320950A (en) Hyaluronidase inhibitor and skin care composition
JP2013129638A (en) Cosmetic material
JP5346540B2 (en) Deodorant / deodorant composition for tobacco odor, and cosmetic composition for hair containing the composition
JP5795146B2 (en) Moisturizer and external preparation for skin
JP2008169196A (en) External preparation for skin
JP2011046646A (en) Antioxidant and skin external preparation
JP2001261567A (en) Skin care preparation
JP2000281553A (en) Sterilizer composition
JP5455634B2 (en) Skin preparations and moisturizers
JP2020094001A (en) Skin external preparation

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181220

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20181220

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20190111

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190402

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190529

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190723

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190903

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190909

R150 Certificate of patent or registration of utility model

Ref document number: 6586506

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150